{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T18:25:33Z","timestamp":1784226333451,"version":"3.55.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ejogrb.2023.10.028","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T21:13:42Z","timestamp":1698354822000},"page":"178-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Botulinum toxin injection in vulva and vagina. Evidence from a literature systematic review"],"prefix":"10.1016","volume":"291","author":[{"given":"Michele","family":"Parenti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca Susanna","family":"Degliuomini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich","family":"Cosmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amerigo","family":"Vitagliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Fasola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Origoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Salvatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9466-0178","authenticated-orcid":false,"given":"Giovanni","family":"Buzzaccarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2023.10.028_b0005","unstructured":"Padda IS, Tadi P (2022) Botulinum Toxin. In: StatPearls. StatPearls Publishing, Treasure Island (FL)."},{"key":"10.1016\/j.ejogrb.2023.10.028_b0010","doi-asserted-by":"crossref","DOI":"10.1128\/mr.56.1.80-99.1992","article-title":"Properties and use of botulinum toxin and other microbial neurotoxins in medicine","author":"Schantz","year":"1992","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0015","article-title":"Botulinum toxins for aesthetic facial injections - a scientific review to support evidence-based best practice","author":"Philipp-Dormston","year":"2022","journal-title":"Facial Plast Surg"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0020","doi-asserted-by":"crossref","unstructured":"Crowley T, Richardson D, Goldmeier D, Bashh Special Interest Group for Sexual Dysfunction (2006) Recommendations for the management of vaginismus: BASHH Special Interest Group for Sexual Dysfunction. Int J STD AIDS 17:14\u201318. https:\/\/doi.org\/10.1258\/095646206775220586.","DOI":"10.1258\/095646206775220586"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0025","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00266-020-02054-w","article-title":"Materials selection for the injection into vaginal wall for treatment of vaginal atrophy","volume":"45","author":"Zheng","year":"2021","journal-title":"Aesthetic Plast Surg"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0030","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.3390\/s21144668","article-title":"Effect of BoNT\/A in the surface electromyographic characteristics of the pelvic floor muscles for the treatment of chronic pelvic pain","volume":"21","author":"Albaladejo-Belmonte","year":"2021","journal-title":"Sensors"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/toxins14010053","article-title":"BoNT\/A in the urinary bladder\u2014more to the story than silencing of cholinergic nerves","volume":"14","author":"Ibrahim","year":"2022","journal-title":"Toxins"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0040","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1080\/13697137.2021.1898580","article-title":"Hyaluronic acid in vulvar and vaginal administration: evidence from a literature systematic review","volume":"24","author":"Buzzaccarini","year":"2021","journal-title":"Climacteric"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0045","unstructured":"(2013) Diagnostic and statistical manual of mental disorders: DSM-5, 5th ed. American psychiatric association, Washington."},{"key":"10.1016\/j.ejogrb.2023.10.028_b0050","doi-asserted-by":"crossref","unstructured":"Bornstein J, Goldstein AT, Stockdale CK, Bergeron S, Pukall C, Zolnoun D, Coady D, consensus vulvar pain terminology committee of the International Society for the Study of Vulvovaginal Disease (ISSVD), the International Society for the Study of Women\u2019s Sexual Health (ISSWSH), and the International Pelvic Pain Society (IPPS) (2016) 2015 ISSVD, ISSWSH and IPPS Consensus Terminology and Classification of Persistent Vulvar Pain and Vulvodynia. Obstet Gynecol 127:745\u2013751. https:\/\/doi.org\/10.1097\/AOG.0000000000001359.","DOI":"10.1097\/AOG.0000000000001359"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0055","unstructured":"Chronic Pelvic Pain: ACOG Practice Bulletin, Number 218 - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/32080051\/. Accessed 1 Feb 2022."},{"key":"10.1016\/j.ejogrb.2023.10.028_b0060","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/0167482X.2015.1103732","article-title":"ISPOG European Consensus Statement - chronic pelvic pain in women (short version)","volume":"36","author":"Siedentopf","year":"2015","journal-title":"J Psychosom Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0065","first-page":"1033","article-title":"Comparison of 500 units vs 250 units of botulinum toxin (abobotulinumtoxinA) for the treatment of severe vaginismus","author":"Ghazizadeh","year":"2016","journal-title":"J Bacteriol Mycol"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0070","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1111\/j.1743-6109.2009.01378.x","article-title":"Botulinum toxin type A-a novel treatment for provoked vestibulodynia? results from a randomized, placebo controlled, double blinded study","volume":"6","author":"Petersen","year":"2009","journal-title":"J Sex Med"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0075","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00404-019-05043-w","article-title":"Subcutaneous botulinum toxin type A injections for provoked vestibulodynia: a randomized placebo-controlled trial and exploratory subanalysis","volume":"299","author":"Diomande","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0080","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/AOG.0000000000004008","article-title":"Botulinum toxin A as a treatment for provoked vestibulodynia: a randomized controlled trial","volume":"136","author":"Haraldson","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0085","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1007\/s00192-018-3836-7","volume":"30","author":"Yaraghi","year":"2019","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0090","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/01.AOG.0000237100.29870.cc","article-title":"Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial","volume":"108","author":"Abbott","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0095","doi-asserted-by":"crossref","first-page":"517.e1","DOI":"10.1016\/j.ajog.2019.06.044","article-title":"A randomized, double-blind, placebo-controlled trial of onabotulinumtoxin A trigger point injections for myofascial pelvic pain","volume":"221","author":"Dessie","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0100","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1111\/j.1743-6109.2011.02247.x","article-title":"Different treatment modalities for refractory vaginismus in western Saudi Arabia","volume":"8","author":"Fageeh","year":"2011","journal-title":"J Sex Med"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0105","article-title":"Botox treatment for vaginismus","volume":"455\u2013456","author":"Pacik","year":"2009","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0110","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4111\/icu.2017.58.2.134","article-title":"Botox combined with myofascial release physical therapy as a treatment for myofascial pelvic pain","volume":"58","author":"Halder","year":"2017","journal-title":"Investig Clin Urol"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0115","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/SPV.0b013e3182989fd8","article-title":"Botulinum toxin type A (BOTOX) for refractory myofascial pelvic pain","volume":"19","author":"Adelowo","year":"2013","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0120","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00192-020-04435-w","article-title":"Botulinum injections for myofascial pelvic pain","volume":"32","author":"Jha","year":"2021","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0125","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4111\/kju.2013.54.1.48","article-title":"A retrospective study of the management of vulvodynia","volume":"54","author":"Jeon","year":"2013","journal-title":"Korean J Urol"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0130","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/AOG.0b013e3181bb0dbb","article-title":"Botulinum neurotoxin type A injections for vaginismus secondary to vulvar vestibulitis syndrome","volume":"114","author":"Bertolasi","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0135","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/01.AOG.0000141441.41178.6b","article-title":"Botulinum toxin in the treatment of refractory vaginismus","volume":"104","author":"Ghazizadeh","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0140","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1016\/j.esxm.2017.02.002","article-title":"Vaginismus treatment: clinical trials follow up 241 patients","volume":"5","author":"Pacik","year":"2017","journal-title":"Sex Med"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0145","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/sj.ijir.3901487","article-title":"Botulinum toxin A for the management of vulvodynia","volume":"19","author":"Yoon","year":"2007","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0150","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejogrb.2018.12.013","article-title":"Botulinum toxin-treatment of localized provoked vulvodynia refractory to conventional treatment","volume":"234","author":"Hedebo Hansen","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0155","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/jdv.13437","article-title":"Long-term assessment of effectiveness and quality of life of OnabotulinumtoxinA injections in provoked vestibulodynia","volume":"30","author":"Pelletier","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0160","doi-asserted-by":"crossref","first-page":"8783","DOI":"10.3390\/ijerph18168783","article-title":"Treatment of dyspareunia with botulinum neurotoxin type A: clinical improvement and influence of patients\u2019 characteristics","volume":"18","author":"Tarazona-Motes","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0165","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.toxicon.2012.11.018","article-title":"Improvement in pelvic pain with botulinum toxin type A - Single vs. repeat injections","volume":"63","author":"Nesbitt-Hawes","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0170","doi-asserted-by":"crossref","first-page":"E65","DOI":"10.3390\/toxins8030065","article-title":"Conversion ratio between Botox\u00ae, Dysport\u00ae, and Xeomin\u00ae in clinical practice","volume":"8","author":"Scaglione","year":"2016","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0175","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/mdc3.12235","article-title":"OnabotulinumtoxinA and AbobotulinumtoxinA dose conversion: a systematic literature review","volume":"3","author":"Dashtipour","year":"2016","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0180","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0002-9378(78)90822-0","article-title":"Vaginismus","volume":"131","author":"Lamont","year":"1978","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0185","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.esxm.2019.07.006","article-title":"Case series: redefining severe grade 5 vaginismus","volume":"7","author":"Pacik","year":"2019","journal-title":"Sex Med"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0190","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/AJP.0b013e31815aac4d","article-title":"The treatment of provoked vestibulodynia: a critical review","volume":"24","author":"Landry","year":"2008","journal-title":"Clin J Pain"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0195","doi-asserted-by":"crossref","first-page":"18S","DOI":"10.1177\/1090820X12474633","article-title":"IncobotulinumtoxinA (Xeomin): background, mechanism of action, and manufacturing","volume":"33","author":"Nahai","year":"2013","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0200","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2165\/11584780-000000000-00000","article-title":"Content of botulinum neurotoxin in Botox\u00ae\/Vistabel\u00ae, Dysport\u00ae\/Azzalure\u00ae, and Xeomin\u00ae\/Bocouture\u00ae","volume":"10","author":"Frevert","year":"2010","journal-title":"Drugs R D"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0205","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1093\/ajhp\/61.suppl_6.S5","article-title":"Pharmacology of botulinum neurotoxin serotype A","volume":"61","author":"Wenzel","year":"2004","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0210","first-page":"357","article-title":"Immunological properties of Hn-33 purified from type A Clostridium botulinum","volume":"9","author":"Sharma","year":"2000","journal-title":"J Nat Toxins"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0215","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1254\/jphs.11060FP","article-title":"Inhibition of membrane Na<SUP>+<\/SUP> channels by A type botulinum toxin at femtomolar concentrations in central and peripheral neurons","volume":"118","author":"Shin","year":"2012","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0220","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1749-6632.2009.05110.x","article-title":"Familial pain syndromes from mutations of the Nav1.7 sodium channel","volume":"1184","author":"Fischer","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0225","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.pain.2013.12.009","article-title":"Botulinum toxin B in the sensory afferent: transmitter release, spinal activation, and pain behavior","volume":"155","author":"Marino","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0230","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pain.2003.10.008","article-title":"Subcutaneous administration of botulinum toxin A reduces formalin-induced pain","volume":"107","author":"Cui","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0235","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1073\/pnas.96.6.3200","article-title":"Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals","volume":"96","author":"de Paiva","year":"1999","journal-title":"PNAS"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0240","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1111\/j.1524-4725.2010.01710.x","article-title":"Antibody-induced failure of botulinum toxin A therapy in cosmetic indications","volume":"36","author":"Dressler","year":"2010","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0245","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1185\/030079904125003962","article-title":"Safety of botulinum toxin type A: a systematic review and meta-analysis","volume":"20","author":"Naumann","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0250","first-page":"3","article-title":"The consensus terminology of persistent vulvar pain and vulvodynia","volume":"37","author":"Bornstein","year":"2018","journal-title":"Pelviperineology"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0255","series-title":"StatPearls","article-title":"Vulvodynia","author":"Faye","year":"2022"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0260","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/j.1532-2149.2014.485.x","article-title":"Pelvic floor muscle dysfunctions are prevalent in female chronic pelvic pain: a cross-sectional population-based study","volume":"18","author":"Loving","year":"2014","journal-title":"Eur J Pain"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0265","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2146\/ajhp050137","article-title":"Unlabeled uses of botulinum toxins: a review, part 1","volume":"63","author":"Cheng","year":"2006","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0270","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0140-6736(05)64862-3","article-title":"Treatment of vaginismus with botulinum toxin injections","volume":"349","author":"Brin","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0275","first-page":"635","article-title":"Subjective and objective outcomes of botulinum toxin type A treatment in vestibulodynia: pilot data","volume":"51","author":"Brown","year":"2006","journal-title":"J Reprod Med"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0280","first-page":"467","article-title":"Botulinum toxin type A for the treatment of provoked vestibulodynia: an open-label, pilot study","volume":"51","author":"Dykstra","year":"2006","journal-title":"J Reprod Med"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0285","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/jabr.12037","article-title":"OnabotulinumtoxinA as part of a multimodal program to treat vaginismus","volume":"20","author":"Pacik","year":"2015","journal-title":"J Appl Biobehav Res"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0290","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000079620","article-title":"Botulinum toxin for the treatment of genital pain syndromes","volume":"58","author":"Romito","year":"2004","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0295","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1080\/01443610050009674","article-title":"Vaginismus: results of treatment with botulin toxin","volume":"20","author":"Shafik","year":"2000","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0300","first-page":"617","article-title":"Efficacy of high doses of botulinum toxin A for treating provoked vestibulodynia","volume":"164","author":"Pelletier","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0305","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jpain.2004.02.575","article-title":"Botulinum toxin a for vulvodynia: a case report","volume":"5","author":"Gunter","year":"2004","journal-title":"J Pain"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0310","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/AOG.0b013e3181998ce1","article-title":"Successful use of botulinum toxin type a in the treatment of refractory postoperative dyspareunia","volume":"114","author":"Park","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0315","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1001\/archdermatol.2010.443","article-title":"Successful treatment of vulvodynia with botulinum toxin A","volume":"147","author":"Tieu","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0320","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1471-0528.2004.00315.x","article-title":"The use of botulinum toxin type A (BOTOX) as treatment for intractable chronic pelvic pain associated with spasm of the levator ani muscles","volume":"112","author":"Thomson","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0325","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jpain.2005.01.353","article-title":"Botulinum toxin a injection of the obturator internus muscle for chronic perineal pain","volume":"6","author":"Gajraj","year":"2005","journal-title":"J Pain"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0330","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1479-828X.2004.00163.x","article-title":"Pilot study of botulinum toxin type A in the treatment of chronic pelvic pain associated with spasm of the levator ani muscles","volume":"44","author":"Jarvis","year":"2004","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0335","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/SPV.0000000000000177","article-title":"Botulinum toxin A injections into pelvic floor muscles under electromyographic guidance for women with refractory high-tone pelvic floor dysfunction: a 6-month prospective pilot study","volume":"21","author":"Morrissey","year":"2015","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0340","doi-asserted-by":"crossref","unstructured":"Tandon HK, Stratton P, Sinaii N, Shah J, Karp BI (2019) Botulinum toxin for chronic pelvic pain in women with endometriosis: a cohort study of a pain-focused treatment. Reg Anesth Pain Med rapm-2019-100529. https:\/\/doi.org\/10.1136\/rapm-2019-100529.","DOI":"10.1136\/rapm-2019-100529"},{"key":"10.1016\/j.ejogrb.2023.10.028_b0345","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/ajo.13396","article-title":"Botulinum toxin A (Botox) injection into muscles of pelvic floor as a treatment for persistent pelvic pain secondary to pelvic floor muscular spasm: a pilot study","volume":"61","author":"Mooney","year":"2021","journal-title":"Aust N Z J Obstet Gynaecol"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211523007893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211523007893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T06:03:12Z","timestamp":1759557792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211523007893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":69,"alternative-id":["S0301211523007893"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2023.10.028","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Botulinum toxin injection in vulva and vagina. Evidence from a literature systematic review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2023.10.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}